Popescu Mihai, Bratu Angelica, Agapie Mihaela, Borjog Tudor, Jafal Mugurel, Sima Romina-Marina, Orban Carmen
Department of Anaesthesia and Intensive Care, "Carol Davila" University of Medicine and Pharmacy, 37 Dionisie Lupu Street, 020021 Bucharest, Romania.
Department of Anaesthesia and Intensive Care, Bucharest University Emergency Hospital, 169 Independentei Street, 050098 Bucharest, Romania.
Biomedicines. 2024 Mar 18;12(3):676. doi: 10.3390/biomedicines12030676.
Acute liver failure represents a life-threatening organ dysfunction with high mortality rates and an urgent need for liver transplantation. The etiology of the disease varies widely depending on various socio-economic factors and is represented mainly by paracetamol overdose and other drug-induced forms of liver dysfunction in the developed world and by viral hepatitis and mushroom poisoning in less developed countries. Current medical care constitutes either specific antidotes or supportive measures to ensure spontaneous recovery. Although it has been proven to have beneficial effects in paracetamol-induced liver failure, N-acetylcysteine is widely used for all forms of acute liver failure. Despite this, few well-designed studies have been conducted on the assessment of the potential benefits, dose regimens, or route of administration of N-acetylcysteine in non-acetaminophen liver failure. This review aims to summarize the current evidence behind the use of this drug in different forms of liver failure.
急性肝衰竭是一种危及生命的器官功能障碍,死亡率高,急需进行肝移植。该病的病因因各种社会经济因素而异,在发达国家主要由对乙酰氨基酚过量及其他药物性肝损伤形式引起,在欠发达国家则主要由病毒性肝炎和蘑菇中毒引起。目前的医疗手段包括使用特效解毒剂或采取支持措施以确保自然恢复。尽管已证实N-乙酰半胱氨酸对乙酰氨基酚所致肝衰竭有有益作用,但它被广泛用于所有形式的急性肝衰竭。尽管如此,针对非对乙酰氨基酚所致肝衰竭中N-乙酰半胱氨酸的潜在益处、给药方案或给药途径评估的精心设计研究却很少。本综述旨在总结该药在不同形式肝衰竭中应用的现有证据。